Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield
Fierce Biotech went through thousands of pages of sealed court documents in the hopes of analyzing what went wrong with the $1.3 billion transaction.
Angus Liu
Oct 2, 2025 3:00am
89bio was left between a Roche and a hard place in buyout talks
Oct 2, 2025 9:55am
Bolt halves workforce again to find cash for cancer drug readout
Oct 2, 2025 6:45am
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
Fierce Biotech Fundraising Tracker: Cartography, OncoC4 & more
Oct 2, 2025 10:30am
Philips, Getinge team up for integrated anesthesia platform
Oct 2, 2025 1:30pm
More News
Medtronic clips EU approval for Penditure LAA implant
Oct 2, 2025 12:00pm
Fierce Biotech Layoff Tracker 2025: Heidelberg, IO & more
Oct 2, 2025 11:00am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
Former Abiomed CEO launches bid for Massachusetts governor
Oct 1, 2025 4:00pm
See more stories